Your prediction
Matthews International Corp. Stock
Pros and Cons of Matthews International Corp. in the next few years
Pros
Cons
Performance of Matthews International Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Matthews International Corp. | 0.000% | 4.237% | 5.128% | 20.235% | 9.333% | -40.580% | -15.172% |
| Vuzix Corp. | 5.710% | -0.494% | -20.724% | 13.195% | -32.530% | -56.812% | -83.833% |
| USANA Health Sciences Inc. | -2.500% | 2.094% | 7.735% | -22.619% | 18.182% | -66.667% | -75.926% |
| Pola Orbis Holdings Inc. | -0.680% | 5.839% | 8.209% | 0.000% | 4.317% | -43.798% | -63.198% |
Comments
News
Eton Pharmaceuticals Q1 Earnings Call Highlights
Eton Pharmaceuticals (NASDAQ:ETON) raised its 2026 revenue outlook after reporting record first-quarter product sales and highlighting early progress from two recent product launches, DESMODA and
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance
Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million?
According to its SEC filing dated May 4, 2026, Matthews International Capital Management LLC purchased 242,785 additional shares of Yum China (NYSE:YUMC) in the first quarter.
The estimated value of


